These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35653645)

  • 1. Improved Binding Affinity and Pharmacokinetics Enable Sustained Degradation of BCL6
    Huckvale R; Harnden AC; Cheung KJ; Pierrat OA; Talbot R; Box GM; Henley AT; de Haven Brandon AK; Hallsworth AE; Bright MD; Akpinar HA; Miller DSJ; Tarantino D; Gowan S; Hayes A; Gunnell EA; Brennan A; Davis OA; Johnson LD; de Klerk S; McAndrew C; Le Bihan YV; Meniconi M; Burke R; Kirkin V; van Montfort RLM; Raynaud FI; Rossanese OW; Bellenie BR; Hoelder S
    J Med Chem; 2022 Jun; 65(12):8191-8207. PubMed ID: 35653645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achieving
    Bellenie BR; Cheung KJ; Varela A; Pierrat OA; Collie GW; Box GM; Bright MD; Gowan S; Hayes A; Rodrigues MJ; Shetty KN; Carter M; Davis OA; Henley AT; Innocenti P; Johnson LD; Liu M; de Klerk S; Le Bihan YV; Lloyd MG; McAndrew PC; Shehu E; Talbot R; Woodward HL; Burke R; Kirkin V; van Montfort RLM; Raynaud FI; Rossanese OW; Hoelder S
    J Med Chem; 2020 Apr; 63(8):4047-4068. PubMed ID: 32275432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of an
    Harnden AC; Davis OA; Box GM; Hayes A; Johnson LD; Henley AT; de Haven Brandon AK; Valenti M; Cheung KJ; Brennan A; Huckvale R; Pierrat OA; Talbot R; Bright MD; Akpinar HA; Miller DSJ; Tarantino D; Gowan S; de Klerk S; McAndrew PC; Le Bihan YV; Meniconi M; Burke R; Kirkin V; van Montfort RLM; Raynaud FI; Rossanese OW; Bellenie BR; Hoelder S
    J Med Chem; 2023 Apr; 66(8):5892-5906. PubMed ID: 37026591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6.
    Kerres N; Steurer S; Schlager S; Bader G; Berger H; Caligiuri M; Dank C; Engen JR; Ettmayer P; Fischerauer B; Flotzinger G; Gerlach D; Gerstberger T; Gmaschitz T; Greb P; Han B; Heyes E; Iacob RE; Kessler D; Kölle H; Lamarre L; Lancia DR; Lucas S; Mayer M; Mayr K; Mischerikow N; Mück K; Peinsipp C; Petermann O; Reiser U; Rudolph D; Rumpel K; Salomon C; Scharn D; Schnitzer R; Schrenk A; Schweifer N; Thompson D; Traxler E; Varecka R; Voss T; Weiss-Puxbaum A; Winkler S; Zheng X; Zoephel A; Kraut N; McConnell D; Pearson M; Koegl M
    Cell Rep; 2017 Sep; 20(12):2860-2875. PubMed ID: 28930682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model.
    Sandhu SK; Volinia S; Costinean S; Galasso M; Neinast R; Santhanam R; Parthun MR; Perrotti D; Marcucci G; Garzon R; Croce CM
    Proc Natl Acad Sci U S A; 2012 Dec; 109(49):20047-52. PubMed ID: 23169640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric Cancers.
    McLachlan T; Matthews WC; Jackson ER; Staudt DE; Douglas AM; Findlay IJ; Persson ML; Duchatel RJ; Mannan A; Germon ZP; Dun MD
    Mol Cancer Res; 2022 Dec; 20(12):1711-1723. PubMed ID: 36166198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
    Parekh S; Polo JM; Shaknovich R; Juszczynski P; Lev P; Ranuncolo SM; Yin Y; Klein U; Cattoretti G; Dalla Favera R; Shipp MA; Melnick A
    Blood; 2007 Sep; 110(6):2067-74. PubMed ID: 17545502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell lymphoma 6 protein stimulates oncogenicity of human breast cancer cells.
    Wu Q; Liu X; Yan H; He YH; Ye S; Cheng XW; Zhu GL; Wu WY; Wang XN; Kong XJ; Xu XC; Lobie PE; Zhu T; Wu ZS
    BMC Cancer; 2014 Jun; 14():418. PubMed ID: 24917186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL.
    Ci W; Polo JM; Cerchietti L; Shaknovich R; Wang L; Yang SN; Ye K; Farinha P; Horsman DE; Gascoyne RD; Elemento O; Melnick A
    Blood; 2009 May; 113(22):5536-48. PubMed ID: 19307668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule-induced polymerization triggers degradation of BCL6.
    Słabicki M; Yoon H; Koeppel J; Nitsch L; Roy Burman SS; Di Genua C; Donovan KA; Sperling AS; Hunkeler M; Tsai JM; Sharma R; Guirguis A; Zou C; Chudasama P; Gasser JA; Miller PG; Scholl C; Fröhling S; Nowak RP; Fischer ES; Ebert BL
    Nature; 2020 Dec; 588(7836):164-168. PubMed ID: 33208943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of the PDCD2 gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas.
    Baron BW; Zeleznik-Le N; Baron MJ; Theisler C; Huo D; Krasowski MD; Thirman MJ; Baron RM; Baron JM
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7449-54. PubMed ID: 17468402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL6 promotes glioma and serves as a therapeutic target.
    Xu L; Chen Y; Dutra-Clarke M; Mayakonda A; Hazawa M; Savinoff SE; Doan N; Said JW; Yong WH; Watkins A; Yang H; Ding LW; Jiang YY; Tyner JW; Ching J; Kovalik JP; Madan V; Chan SL; Müschen M; Breunig JJ; Lin DC; Koeffler HP
    Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3981-3986. PubMed ID: 28356518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma.
    Dupont T; Yang SN; Patel J; Hatzi K; Malik A; Tam W; Martin P; Leonard J; Melnick A; Cerchietti L
    Oncotarget; 2016 Jan; 7(3):3520-32. PubMed ID: 26657288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Casein kinase II inhibitor CX-4945 on BCL6-mediated apoptotic signaling in B-ALL in vitro and in vivo.
    Richter A; Sender S; Lenz A; Schwarz R; Hinz B; Knuebel G; Sekora A; Murua Escobar H; Junghanss C; Roolf C
    BMC Cancer; 2020 Mar; 20(1):184. PubMed ID: 32131762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic activity of Card11 mutant and Bcl6 in the development of diffuse large B-cell lymphoma in a mouse model.
    Takahara T; Matsuo K; Seto M; Nakamura S; Tsuzuki S
    Cancer Sci; 2016 Nov; 107(11):1572-1580. PubMed ID: 27560392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival.
    Lu X; Fernando TM; Lossos C; Yusufova N; Liu F; Fontán L; Durant M; Geng H; Melnick J; Luo Y; Vega F; Moy V; Inghirami G; Nimer S; Melnick AM; Lossos IS
    Blood; 2018 Nov; 132(19):2026-2039. PubMed ID: 30082494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL6 represses NFkappaB activity in diffuse large B-cell lymphomas.
    Perez-Rosado A; Artiga M; Vargiu P; Sanchez-Aguilera A; Alvarez-Barrientos A; Piris M
    J Pathol; 2008 Mar; 214(4):498-507. PubMed ID: 18189332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional studies of BCL11A: characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cells.
    Liu H; Ippolito GC; Wall JK; Niu T; Probst L; Lee BS; Pulford K; Banham AH; Stockwin L; Shaffer AL; Staudt LM; Das C; Dyer MJ; Tucker PW
    Mol Cancer; 2006 May; 5():18. PubMed ID: 16704730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo.
    Cerchietti LC; Yang SN; Shaknovich R; Hatzi K; Polo JM; Chadburn A; Dowdy SF; Melnick A
    Blood; 2009 Apr; 113(15):3397-405. PubMed ID: 18927431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma.
    Wu WR; Lin JT; Pan CT; Chan TC; Liu CL; Wu WJ; Sheu JJ; Yeh BW; Huang SK; Jhung JY; Hsiao MS; Li CF; Shiue YL
    Theranostics; 2020; 10(2):707-724. PubMed ID: 31903146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.